Historical record - last NADAC effective date: 11/22/2017
Product Information
GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.0461 per EA under NDC 23155023305. Its NADAC has been published 235 times since Nov 28, 2013.
FDA first approved this application on Jun 3, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1.25; 250 mg/1; mg/1
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155023305
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
11/22/2017
Active Ingredients
GLYBURIDE; METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA079009FDA Approved
6/3/2009
TE Code
AB
On Market Since
5/1/2024
Pharmacological Classes
Price Statistics
The NADAC for GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET has been published 235 times since Nov 28, 2013, and over the history we have for it it has declined 47.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0461 per EA |
|---|---|
| All-time high | $0.0908 (May 11, 2016) |
| All-time low | $0.0461 (Nov 22, 2017) |
| Median price | $0.0717 |
| Average price | $0.0698 |
| Largest weekly change | +37.5% (Jun 22, 2016) |
| Weeks tracked | 235 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-47.3%
Last surveyed May 23, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Heritage Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
glyburide-metformin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Biguanide class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET, manufactured by Heritage Pharmaceuticals Inc., is $0.0461 per EA (NDC 23155023305), effective May 23, 2018.
How has the price of GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET has declined 47.3%. It has been tracked across 235 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET?
Since Nov 28, 2013, the NADAC for GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET has ranged from a low of $0.0461 (Nov 22, 2017) to a high of $0.0908 (May 11, 2016), with a median of $0.0717 per EA.
Are there cheaper alternatives to GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET, is $0.0335 per EA — about 27% below GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET.
Who manufactures GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET?
GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET (NDC 23155023305) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.